share_log

Maxim Group Initiates Coverage On Alimera Sciences With Buy Rating, Announces Price Target of $10

Moomoo 24/7 ·  Mar 25 08:03

Maxim Group analyst Naz Rahman initiates coverage on Alimera Sciences (NASDAQ:ALIM) with a Buy rating and announces Price Target of $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment